KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
is optimistic that its efforts in cell therapy, genetic screening and clinical trials are foundational for its future growth and sustainability.
"In fact, prospects for Malaysian Genomics remain robust. The group is well-positioned as a leading provider of genetic screening, genome analysis, and biopharmaceutical products and services in Southeast Asia.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
